Branched DNA technology in molecular diagnostics.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 16880139.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Viral quantification or viral load testing has become part of the routine management of patients infected with HIV-1 or hepatitis C virus (HCV). There are currently several molecular technologies that are available for use in the clinical laboratory setting. Of these, only the branched DNA (bDNA) assays are FDA-approved for HIV-1 and HCV viral load testing. This signal amplification technology is built on a series of hybridization reactions that are highly amenable to full automation and thus lessen the amount of labor required to perform this type of analysis. This article provides a historical perspective of bDNA and its clinical applications.
Medical subject headings
- DNA, Viral
- HIV-1
- Hepacivirus
- Nucleic Acid Amplification Techniques
- RNA, Viral